S100A9 and peripheral arterial disease: A recent report by Saenz‐Pipaon et al.122revealed that S100A9 mRNA is abundant in extracellular vesicles and plasma of PAD patients and increased with the severity of PAD, suggesting S100A9 as a biomarker for predicting the severity of PAD.